These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15900266)

  • 21. So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not?
    Warkentin TE; Greinacher A
    Chest; 2007 Oct; 132(4):1108-10. PubMed ID: 17934108
    [No Abstract]   [Full Text] [Related]  

  • 22. Evolving management strategies for heparin-induced thrombocytopenia.
    Rice L
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S15-21. PubMed ID: 16105554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Argatroban for Treatment of Heparin-Induced Thrombocytopenia and Thrombosis in a Patient with Multiple Myeloma Undergoing Hemodialysis.
    Giorgi-Pierfranceschi M; Mumoli N; Scarpioni R; Croci E; Dentali F
    J Am Geriatr Soc; 2016 Aug; 64(8):1748-50. PubMed ID: 27448437
    [No Abstract]   [Full Text] [Related]  

  • 24. Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgery.
    Koster A; Hentschel T; Groman T; Kuppe H; Hetzer R; Harder S; Fischer KG
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1376-7. PubMed ID: 17467467
    [No Abstract]   [Full Text] [Related]  

  • 25. Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.
    Rice L; Hursting MJ; Baillie GM; McCollum DA
    J Clin Pharmacol; 2007 Aug; 47(8):1028-34. PubMed ID: 17525167
    [No Abstract]   [Full Text] [Related]  

  • 26. A report of outcomes after orthotopic liver transplant with allografts from heparin antibody-positive donors.
    Aloia TA; Goss JA
    Exp Clin Transplant; 2009 Mar; 7(1):13-7. PubMed ID: 19364306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choice of drugs for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 2012 May; 54(1391):43-4. PubMed ID: 22643441
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombosis of biatrial appendages due to heparin-induced thrombocytopenia.
    Munakata M; Hatakeyama M; Ono Y
    Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):245-6. PubMed ID: 24532637
    [No Abstract]   [Full Text] [Related]  

  • 29. Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: first results from the ARG-E03 trial.
    Koster A; Buz S; Hetzer R; Kuppe H; Breddin K; Harder S
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):699-700. PubMed ID: 16935137
    [No Abstract]   [Full Text] [Related]  

  • 30. Argatroban as a heparin substitute in cases of heparin-induced thrombocytopenia.
    Shrager JB; Kaiser LR
    Ann Thorac Surg; 2004 Dec; 78(6):2208; author reply 2208-9. PubMed ID: 15561082
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia.
    Pötzsch B; Klövekorn WP; Madlener K
    N Engl J Med; 2000 Aug; 343(7):515. PubMed ID: 10950681
    [No Abstract]   [Full Text] [Related]  

  • 32. Complete salvage of impending free flap failure in heparin induced thrombocytopenia by emergent institution of therapy with argatroban.
    Schleich AR; Oswald TM; Lineaweaver WC
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1263-4. PubMed ID: 18632316
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban.
    Zayac EA; Pivalizza EG; Levine RL
    Anesth Analg; 2008 Jan; 106(1):351-2. PubMed ID: 18165611
    [No Abstract]   [Full Text] [Related]  

  • 34. Thromboembolism.
    Fitzmaurice D; Hobbs FD; McManus R
    Clin Evid; 2002 Dec; (8):209-24. PubMed ID: 12603878
    [No Abstract]   [Full Text] [Related]  

  • 35. Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: a case report.
    Godier A; Flaujac C; Horellou MH; De Mesmay M; Bécanne X; Parisot M; Gauzit R; Samama CM
    Thromb Res; 2010 Aug; 126(2):e141-3. PubMed ID: 20116834
    [No Abstract]   [Full Text] [Related]  

  • 36. The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.
    Prechel M; Walenga JM
    Semin Thromb Hemost; 2008 Feb; 34(1):86-96. PubMed ID: 18393145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
    Shapiro NL; Durr EA; Krueger CD
    Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombolytic therapy and thrombectomy in phlegmasia cerulea dolens.
    Oo TH
    J R Coll Physicians Edinb; 2010 Mar; 40(1):92. PubMed ID: 21125045
    [No Abstract]   [Full Text] [Related]  

  • 39. Deep vein thrombosis and anticoagulant therapy.
    Sullano MA; Ortiz EJ
    Nurs Clin North Am; 2001 Dec; 36(4):645-63, v. PubMed ID: 11726345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic end point for assessing argatroban therapy for heparin-induced thrombocytopenia: learning from secondary analyses of prospective studies.
    Warkentin TW
    Chest; 2006 Jun; 129(6):1396-8. PubMed ID: 16778250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.